These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29932325)

  • 1. Total Synthesis and Full Structural Assignment of Namenamicin.
    Nicolaou KC; Li R; Lu Z; Pitsinos EN; Alemany LB
    J Am Chem Soc; 2018 Jul; 140(26):8091-8095. PubMed ID: 29932325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
    Nicolaou KC; Rigol S
    Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Synthesis of Trioxacarcins DC-45-A1, A, D, C, and C7″-epi-C and Full Structural Assignment of Trioxacarcin C.
    Nicolaou KC; Cai Q; Sun H; Qin B; Zhu S
    J Am Chem Soc; 2016 Mar; 138(9):3118-24. PubMed ID: 26910506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) Payloads.
    Puthenveetil S; Loganzo F; He H; Dirico K; Green M; Teske J; Musto S; Clark T; Rago B; Koehn F; Veneziale R; Falahaptisheh H; Han X; Barletta F; Lucas J; Subramanyam C; O'Donnell CJ; Tumey LN; Sapra P; Gerber HP; Ma D; Graziani EI
    Bioconjug Chem; 2016 Aug; 27(8):1880-8. PubMed ID: 27412791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined Total Synthesis of Uncialamycin and Its Application to the Synthesis of Designed Analogues for Biological Investigations.
    Nicolaou KC; Wang Y; Lu M; Mandal D; Pattanayak MR; Yu R; Shah AA; Chen JS; Zhang H; Crawford JJ; Pasunoori L; Poudel YB; Chowdari NS; Pan C; Nazeer A; Gangwar S; Vite G; Pitsinos EN
    J Am Chem Soc; 2016 Jul; 138(26):8235-46. PubMed ID: 27266267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
    Chen H; Lin Z; Arnst KE; Miller DD; Li W
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis and complete configurational assignment of amphirionin-2.
    Kato S; Mizukami D; Sugai T; Tsuda M; Fuwa H
    Chem Sci; 2020 Nov; 12(3):872-879. PubMed ID: 34163854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-drug conjugates--an emerging class of cancer treatment.
    Diamantis N; Banerji U
    Br J Cancer; 2016 Feb; 114(4):362-7. PubMed ID: 26742008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-drug conjugates: Current status and future perspectives.
    Gébleux R; Casi G
    Pharmacol Ther; 2016 Nov; 167():48-59. PubMed ID: 27492898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies.
    Rios-Doria J; Harper J; Rothstein R; Wetzel L; Chesebrough J; Marrero A; Chen C; Strout P; Mulgrew K; McGlinchey K; Fleming R; Bezabeh B; Meekin J; Stewart D; Kennedy M; Martin P; Buchanan A; Dimasi N; Michelotti E; Hollingsworth R
    Cancer Res; 2017 May; 77(10):2686-2698. PubMed ID: 28283653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
    Vezina HE; Cotreau M; Han TH; Gupta M
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S11-S25. PubMed ID: 28921650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications.
    Maderna A; Doroski M; Subramanyam C; Porte A; Leverett CA; Vetelino BC; Chen Z; Risley H; Parris K; Pandit J; Varghese AH; Shanker S; Song C; Sukuru SC; Farley KA; Wagenaar MM; Shapiro MJ; Musto S; Lam MH; Loganzo F; O'Donnell CJ
    J Med Chem; 2014 Dec; 57(24):10527-43. PubMed ID: 25431858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
    Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
    Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Synthesis, Stereochemical Revision, and Biological Reassessment of Mandelalide A: Chemical Mimicry of Intrafamily Relationships.
    Willwacher J; Heggen B; Wirtz C; Thiel W; Fürstner A
    Chemistry; 2015 Jul; 21(29):10416-30. PubMed ID: 26094957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-drug conjugates—a new wave of cancer drugs.
    Bouchard H; Viskov C; Garcia-Echeverria C
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5357-63. PubMed ID: 25455482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cryptophycins as potent payloads for antibody drug conjugates.
    Verma VA; Pillow TH; DePalatis L; Li G; Phillips GL; Polson AG; Raab HE; Spencer S; Zheng B
    Bioorg Med Chem Lett; 2015 Feb; 25(4):864-8. PubMed ID: 25613677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
    Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
    ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.